1071520-38-1

Basic information

• Product Name: (1R,2S,3R,4S)-3-ethoxycarbonyl-bicyclo [2.2.1]hept-2-yl-aminium (S)-α-hydroxyphenylacetate
• Synonyms: (1R,2S,3R,4S)-3-ethoxycarbonyl-bicyclo [2.2.1]hept-2-yl-aminium (S)-α-hydroxyphenylacetate
• CAS NO: 1071520-38-1
• Molecular Weight: 335.4
• Mol File: 1071520-38-1.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: (1R,2S,3R,4S)-3-ethoxycarbonyl-bicyclo [2.2.1]hept-2-yl-aminium (S)-α-hydroxyphenylacetate(CAS DataBase Reference)
• NIST Chemistry Reference: (1R,2S,3R,4S)-3-ethoxycarbonyl-bicyclo [2.2.1]hept-2-yl-aminium (S)-α-hydroxyphenylacetate(1071520-38-1)
• EPA Substance Registry System: (1R,2S,3R,4S)-3-ethoxycarbonyl-bicyclo [2.2.1]hept-2-yl-aminium (S)-α-hydroxyphenylacetate(1071520-38-1)

Safety Data

• Hazardous Substances Data: 1071520-38-1(Hazardous Substances Data)

Upstream product

• 105786-35-4 (rac-di-exo)-3-amino-bicyclo[2.2.1]heptane-2-carboxylic acid ethyl ester 
• 95630-75-4 ethyl exo-3-aminobicyclo<2.2.1>heptane-2-exo-carboxylate hydrochloride 
• 179462-36-3 (±)-cis-3-aminobicyclo[2.2.1]heptane-2-carboxylic acid hydrochloride 
• 7486-95-5 exo-3-azatricyclo<4.2.1.0^2,5>nonan-4-one 
• 1071520-32-5 (1S,2S,3R,4R)-3-ethoxycarbonyl-bicyclo[2.2.1]hept-2-yl-ammonium (1'S)-(+)-10-camphorsulfonate 
• 498-66-8 norborn-2-ene 
• 17199-29-0 (S)-Mandelic acid 
• 785027-31-8 (1R,2R,3S,4S)-3-amino-bicyclo[2.2.1]heptane-2-carboxylic acid ethyl ester 

Relevant articles and documents

A METHOD OF INHIBITING HEPATITIS C VIRUS BY COMBINATION OF A 5,6-DIHYDRO-1H-PYRIDIN-2-ONE AND ONE OR MORE ADDITIONAL ANTIVIRAL COMPOUNDS

The invention is directed to a method of treating infections by hepatitis C virus by administering N-{3-[(1R,2S,7R,8S)-3-(4-fluoro-benzyl)-6-hydroxy-4-oxo-3-aza-tricyclo[6.2.1.02,7]undec-5-en-5-yl]-1,1 -dioxo-l,4-dihydro-lλ6- benzo[l,2,4]thiadiazin-7-yl} -methanesulfonamide and one or more additional antiviral compounds or pharmaceutical compositions containing such compounds.

5,6-DIHYDRO-1H-PYRIDIN-2-ONE COMPOUNDS

The invention is directed to 5,6-dihydro-lH-pyridin-2-one compounds and pharmaceutical compositions containing such compounds that are useful in treating infections by hepatitis C virus.